Presentation is loading. Please wait.

Presentation is loading. Please wait.

Introduction of Parasympatholytics: M blockers: Atropine, Cyclopentolate, Scopolamine, Tropicamide N1 Blockers: Nicotine N2 Blockers: Tubocurarine,

Similar presentations


Presentation on theme: "Introduction of Parasympatholytics: M blockers: Atropine, Cyclopentolate, Scopolamine, Tropicamide N1 Blockers: Nicotine N2 Blockers: Tubocurarine,"— Presentation transcript:

1 Introduction of Parasympatholytics: M blockers: Atropine, Cyclopentolate, Scopolamine, Tropicamide N1 Blockers: Nicotine N2 Blockers: Tubocurarine, Atracurium

2 Parasympatholytic Atropine Pharmaceutical chemistry Possible Origin
Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Anti-muscarinic Structure-based explanation of Therapeutic uses: Mydriatic for measuring refractive errors of the eyes, (week-2 week duration). Replaced by short acting anti-cholinergics, Antispasmodic, anti-dote for mushroom poisoning and antisecretory. Structure-based explanation of Side effects: dry mouth, blurred vision, Sandy eyes, tachycardia, constipation, restless and confusion. Analysis

3 Parasympatholytic Cyclopentolate (Cyclogyl) Pharmaceutical chemistry
Possible Origin Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Structure-based explanation of Therapeutic uses: short acting for mydriasis (24 hours) Structure-based explanation of Side effects: Analysis

4 Parasympatholytic Scopolamine Pharmaceutical chemistry Possible Origin
Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Structure-based explanation of Therapeutic uses: motion sickness, block short-term memory and anti-spasmodic Structure-based explanation of Side effects: Analysis

5 Parasympatholytic Tropicamide (Mydriacyl) Pharmaceutical chemistry
Possible Origin Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Structure-based explanation of Therapeutic uses: short acting for mydriasis (6 hours) Structure-based explanation of Side effects: Analysis

6 Parasympatholytic Nicotine (Nicotinell) Pharmaceutical chemistry
Possible Origin Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Ganglionic blocker (N2) Structure-based explanation of Therapeutic uses: none Structure-based explanation of Side effects: stimulation then paralysis of Ganglionic receptor, high blood pressure, increasing cardiac output, hypotension with high doses and low GI activity. Analysis

7 Parasympatholytic Tubocurarine Pharmaceutical chemistry
Possible Origin Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Neuromuscular blocker (N1) Structure-based explanation of Therapeutic uses: Adjuvant drug in anaesthesia to facilitate intubation. Structure-based explanation of Side effects: it sometimes increases histamine release and causes hypotension (allergy). Thus it is rarely used. Analysis

8 Parasympatholytic Atracurium (Tracrium) Pharmaceutical chemistry
Possible Origin Physiochemical Properties Idea of Retro-synthesis Molecular pharmacology Mechanism of action: Structure-based explanation of Therapeutic uses: Structure-based explanation of Side effects: well-tolerated Analysis


Download ppt "Introduction of Parasympatholytics: M blockers: Atropine, Cyclopentolate, Scopolamine, Tropicamide N1 Blockers: Nicotine N2 Blockers: Tubocurarine,"

Similar presentations


Ads by Google